Cargando…

Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study

OBJECTIVE: To estimate the effectiveness of maternal mRNA covid-19 vaccination during pregnancy against delta and omicron severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and hospital admission in infants. DESIGN: Test negative design study. SETTING: Community and hospital test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorgensen, Sarah C J, Hernandez, Alejandro, Fell, Deshayne B, Austin, Peter C, D’Souza, Rohan, Guttmann, Astrid, Brown, Kevin A, Buchan, Sarah A, Gubbay, Jonathan B, Nasreen, Sharifa, Schwartz, Kevin L, Tadrous, Mina, Wilson, Kumanan, Kwong, Jeffrey C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903336/ https://www.ncbi.nlm.nih.gov/pubmed/36754426 http://dx.doi.org/10.1136/bmj-2022-074035

Ejemplares similares

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
por: Buchan, Sarah A., et al.
Publicado: (2022)

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study
por: Chung, Hannah, et al.
Publicado: (2022)

Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
por: Chung, Hannah, et al.
Publicado: (2021)

Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments
por: Sundaram, Maria, et al.
Publicado: (2021)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
por: Nasreen, Sharifa, et al.
Publicado: (2022)

Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study
por: Cheng, Daryl R, et al.
Publicado: (2023)

Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination
por: Fell, Deshayne B., et al.
Publicado: (2016)

Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis
por: Hawken, Steven, et al.
Publicado: (2019)

COVID‐19 pandemic and population‐level pregnancy and neonatal outcomes in general population: A living systematic review and meta‐analysis (Update#2: November 20, 2021)
por: Yang, Jie, et al.
Publicado: (2022)

Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021
por: Ravindran, Saranyah, et al.
Publicado: (2023)

Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study
por: Walsh, Laura K, et al.
Publicado: (2019)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2022)

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2023)

The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads
por: Fall, Amary, et al.
Publicado: (2022)

Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study
por: Antoniou, Tony, et al.
Publicado: (2023)

Coronavirus disease 2019 pandemic and pregnancy and neonatal outcomes in general population: A living systematic review and meta‐analysis (updated Aug 14, 2021)
por: Yang, Jie, et al.
Publicado: (2021)

Incidence and severity of pulmonary embolism in COVID-19 infection: Ancestral, Alpha, Delta, and Omicron variants
por: Wada, Noriaki, et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

The Detection of Periodic Reemergence Events of SARS-CoV-2 Delta Strain in Communities Dominated by Omicron
por: Westcott, Claire E., et al.
Publicado: (2022)

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
por: Grewal, Ramandip, et al.
Publicado: (2022)

Association between newborn screening analyte profiles and infant mortality
por: Fell, Deshayne B., et al.
Publicado: (2019)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Temporal trends in the frequency of twins and higher-order multiple births in Canada and the United States
por: Fell, Deshayne B, et al.
Publicado: (2012)

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
por: Bolze, Alexandre, et al.
Publicado: (2022)

Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19
por: Schwartz, Kevin L., et al.
Publicado: (2023)

Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy
por: Török, Eszter, et al.
Publicado: (2023)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada
por: El-Chaâr, Darine, et al.
Publicado: (2022)

Estimating the Incidence of First RSV Hospitalization in Children Born in Ontario, Canada
por: Buchan, Sarah A, et al.
Publicado: (2023)

Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study
por: Fell, Deshayne B., et al.
Publicado: (2023)

Adolescent COVID-19 Cases During the SARS-CoV-2 Delta and Omicron Variant Surges in Kentucky: Association With Vaccination and Prior Infection
por: Spicer, Kevin B., et al.
Publicado: (2023)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

Long covid risk with omicron may be half that of delta
por: Wilson, Clare
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nucp3e62gp73jh9e1n0qr2k4ds